Works matching DE "LIRAGLUTIDE"


Results: 405
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study).

    Published in:
    Metabolites (2218-1989), 2025, v. 15, n. 6, p. 398, doi. 10.3390/metabo15060398
    By:
    • Al-Najim, Werd;
    • Dehestani, Babak;
    • Al-Humadi, Ahmed W.;
    • Bodicoat, Danielle H.;
    • Papamargaritis, Dimitris;
    • Lean, Michael;
    • McGowan, Barbara;
    • Webb, David R.;
    • Wilding, John PH;
    • Davies, Melanie J.;
    • le Roux, Carel W.
    Publication type:
    Article
    14
    15
    16
    17
    18

    Dapagliflozin, Liraglutide, and Their Combination Attenuate Diabetes Mellitus-Associated Hepato-Renal Injury—Insight into Oxidative Injury/Inflammation/Apoptosis Modulation.

    Published in:
    Life (2075-1729), 2022, v. 12, n. 5, p. 764, doi. 10.3390/life12050764
    By:
    • El-Sherbiny, Mohamed;
    • El-Shafey, Mohamed;
    • Said, Eman;
    • Shaker, Gehan Ahmed;
    • El-Dosoky, Mohamed;
    • Ebrahim, Hasnaa Ali;
    • Abed, Sally Yussef;
    • Ibraheem, Khalid M.;
    • Mohsen Faheem, Ahmed;
    • AlMutawa, Muntazar;
    • Alatawi, Bayader;
    • Elsherbiny, Nehal M.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    A Randomized, Double-Blind, Two-Way Cross-over Study to Evaluate the Efficacy of Liraglutide Treatment in Patients Undergoing Transoral Outlet Reduction Endoscopy for Weight Regain Post Roux-en-Y Gastric Bypass.

    Published in:
    Obesity Surgery, 2025, v. 35, n. 3, p. 775, doi. 10.1007/s11695-025-07671-5
    By:
    • Lahooti, Ali;
    • Hoff, Anna C.;
    • Critelli, Brian;
    • Hassan, Amier;
    • Westerveld, Donevan;
    • Hajifathalian, Kaveh;
    • Dawod, Enad;
    • Akagbosu, Cynthia O.;
    • Aljohani, Waleed;
    • Hassan, Kamal;
    • Nunes, Gabriel Cairo;
    • Barrichello, Sergio;
    • Neto, Manoel Galvao;
    • Scarparo, Jimi;
    • Newberry, Carolyn;
    • Kumar, Sonal;
    • Sharaiha, Reem Z.
    Publication type:
    Article
    35
    36
    37
    38
    39
    41
    42
    43
    44
    45
    46
    47
    48

    Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.

    Published in:
    Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02237-8
    By:
    • Grannes, Helene;
    • Ueland, Thor;
    • Simeone, Paola;
    • Liani, Rossella;
    • Guagnano, Maria Teresa;
    • Aukrust, Pål;
    • Michelsen, Annika E.;
    • Birkeland, Kåre;
    • di Castelnuovo, Augusto;
    • Cipollone, Francesco;
    • Consoli, Agostino;
    • Halvorsen, Bente;
    • Gregersen, Ida;
    • Santilli, Francesca
    Publication type:
    Article
    49

    Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.

    Published in:
    Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01845-0
    By:
    • Denimal, Damien;
    • Bergas, Victoria;
    • Pais-de-Barros, Jean-Paul;
    • Simoneau, Isabelle;
    • Demizieux, Laurent;
    • Passilly-Degrace, Patricia;
    • Bouillet, Benjamin;
    • Petit, Jean-Michel;
    • Rouland, Alexia;
    • Bataille, Amandine;
    • Duvillard, Laurence;
    • Vergès, Bruno
    Publication type:
    Article
    50